The cost impact of disease progression to metastatic castration-sensitive prostate cancer

BACKGROUND: Metastatic prostate cancer (PC) is associated with declining survival rates and increased health care expenditure. However, there are few studies quantifying these increased costs. OBJECTIVE: To estimate overall health care resource utilization and costs associated with progression to me...

Descripción completa

Detalles Bibliográficos
Autores principales: Trinh, Quoc-Dien, Chaves, Leonardo Passos, Feng, Qi, Zhu, Julia, Sandin, Rickard, Abbott, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373041/
https://www.ncbi.nlm.nih.gov/pubmed/35471070
http://dx.doi.org/10.18553/jmcp.2022.28.5.544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373041/
https://www.ncbi.nlm.nih.gov/pubmed/35471070
http://dx.doi.org/10.18553/jmcp.2022.28.5.544

Ejemplares similares